Atlas Trials

Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)

Clinical trial NCT06682195 · RECRUITING

Trial details

NCT number
NCT06682195
Sponsor
First Affiliated Hospital of Zhejiang University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
TNBC, Triple Negative Breast Cancer
Start date
2024-10-09
Primary completion
2026-10-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.